Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |